-

COVID-19 Vaccine Developments Subscription: Therapeutics Experiments and Diagnostics/Devices Advances - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "COVID-19 - Vaccine Development, Therapeutics Experiments and Diagnostics/devices advances - Premium Bundle" report has been added to ResearchAndMarkets.com's offering.

The COVID-19 - Vaccine Development, Therapeutics Experiments and Diagnostics/devices advances - Premium Bundle includes:

  • Subscription to 6 Dailies
  • Subscription to 6 Weekly Summary Reports
  • Subscription to 6 Monthly Synthesis Reports

Choices available to choose from:

Daily: 27 Daily reports available

To choose one Daily report from the available Categories, Regions, Healthcare sub-industries and Market capitalization levels

Weekly: 15 Weekly summary reports available

To choose one Weekly summary report from the available Categories, Regions, Healthcare sub-industries and Market capitalization levels

Monthly: 22 Monthly synthesis reports available

To choose one Monthly report from the available sub-categories within each of the three categories

Key Topics Covered:

Coverage - Daily Reports:

  • Daily report offer at five different time zones, daily updates for 20+ global news each related to COVID-19 Vaccine Development, Therapeutics Experiments, and Diagnostics/Devices Advances, comprehensively compiled and curated from global as well as regional and local news media.
  • Daily report offers 20+ COVID-19 business news for the last 24-48 hours, comprehensively compiled and curated from regional and local news media, and summarized succinctly for each of the 4 key regions - Americas, Asia, Emerging Markets, and Europe
  • Daily report offers 20+ COVID-19 business news for the last 24-48 hours, comprehensively compiled and curated from regional and local news media, and summarized succinctly for each of the 4 healthcare sub-industries - Biotechnology, Healthcare Services, Medical Devices, and Pharmaceuticals
  • Daily report offers 20+ COVID-19 business news for the last 24-48 hours, comprehensively compiled and curated from regional and local news media, and summarized succinctly for each of the 4 market capitalization levels - LargeCap Companies, Small-MidCap Companies, Privately-Owned Companies, and Non-Profit Organizations

Coverage - Weekly Summary Reports:

  • A weekly presentation of all the recent crucial development related to COVID-19 Vaccine Development, Therapeutics Experiments, and Diagnostics/Devices Advances
  • Recent crucial development of the week relevant to COVID-19 business news related to Vaccine Development, Therapeutics Experiments, and Diagnostics/Devices Advances for American, Asian, Emerging Market, and European companies, research institutes, academia, and healthcare organizations rounded up and summarized succinctly to present a complete overview of the current happenings
  • Recent crucial development of the week relevant to COVID-19 business news related to Vaccine Development, Therapeutics Experiments, and Diagnostics/Devices Advances for Biotechnology, Healthcare Services, Medical Devices, and Pharmaceutical companies worldwide rounded up and summarized succinctly to present a complete overview of the current happenings
  • Recent crucial development of the week relevant to COVID-19 business news related to Vaccine Development, Therapeutics Experiments, and Diagnostics/Devices Advances for LargeCap, Small-MidCap, and Privately-owned companies, and Non-Profit organizations worldwide rounded up and summarized succinctly to present a complete overview of the current happenings

Coverage - Monthly Synthesis Reports:

  • A monthly overview on key updates with analysis offered for each of the different sub-categories of Vaccine Development such as Clinical/Human Trials, Global Grants/Funding, Licensing, Manufacturing/Purchasing/Selling, Regulatory Approvals, and Research/Studies
  • A monthly overview on key updates with analysis offered for each of the different sub-categories of Therapeutics Experiments such as Clinical Trials, Global Grants/Funding, Existing Medicines Research, Licensing, Manufacturing/Production/Selling, Regulatory Approvals, Research/Studies, and Treatment/Therapies
  • A monthly overview on key updates with analysis offered for each of the different sub-categories of Diagnostics/Devices Advances such as Global Grants/Funding, Licensing, Manufacturing/Development/Production, Regulatory Approvals, Research/Studies, Technology Updates, Testing, and Testing Kits/Facilities/Sites

For more information about this report visit https://www.researchandmarkets.com/r/u4nian

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Industry:

Research and Markets

Release Versions
English

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

1 Day Clinical Trial Agreements Training Course: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets (Mar 18, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Trial Agreements: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets Training Course (Mar 18, 2026)" training has been added to ResearchAndMarkets.com's offering. The life sciences sector is heavily regulated and CTAs are some of the most important agreements for companies operating in this sector. Having appropriate CTAs in place is therefore essential for managing relationships between the diffe...

Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026)" training has been added to ResearchAndMarkets.com's offering. Understand the regulatory frameworks governing drug/device and device/drug combinations in the European Union and the USA. The demarcation between medicinal products and devices is becoming ever more important and, with the conve...

Wedding Rings Market Trends, Shares and Growth Prospects 2025-2030 - Cultural and Social Trends Around Minimalism and Modern Design Drive Adoption of Non-Traditional Styles - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Wedding Rings - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Wedding Rings was valued at US$56.7 Billion in 2024 and is projected to reach US$80.7 Billion by 2030, growing at a CAGR of 6.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The wedding ring market is expanding due to a combin...
Back to Newsroom